SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-034154
Filing Date
2020-03-16
Accepted
2020-03-16 17:03:33
Documents
93
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm2031081-1_10k.htm 10-K 1545986
2 EXHIBIT 4.3 tm2031081d1_ex4-3.htm EX-4.3 26885
3 EXHIBIT 21.1 tm2031081d1_ex21-1.htm EX-21.1 1397
4 EXHIBIT 23.1 tm2031081d1_ex23-1.htm EX-23.1 5520
5 EXHIBIT 31.1 tm2031081d1_ex31-1.htm EX-31.1 7986
6 EXHIBIT 31.2 tm2031081d1_ex31-2.htm EX-31.2 8212
7 EXHIBIT 32.1 tm2031081d1_ex32-1.htm EX-32.1 3717
8 EXHIBIT 32.2 tm2031081d1_ex32-2.htm EX-32.2 3390
15 GRAPHIC tm2031081-1_10kimg01.jpg GRAPHIC 21934
  Complete submission text file 0001104659-20-034154.txt   9354113

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT stml-20191231.xml EX-101.INS 2434502
10 XBRL TAXONOMY EXTENSION SCHEMA stml-20191231.xsd EX-101.SCH 72027
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stml-20191231_cal.xml EX-101.CAL 80204
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stml-20191231_def.xml EX-101.DEF 223723
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE stml-20191231_lab.xml EX-101.LAB 655540
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stml-20191231_pre.xml EX-101.PRE 452525
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35619 | Film No.: 20718017
SIC: 2834 Pharmaceutical Preparations